The programme, which is focused on providing preventive and personalised healthcare for citizens of the United Arab Emirates, wants more citizens to offer samples, The Emirati Genome Program, an initiative focused on providing preventive and personalised healthcare for citizens of the United Arab Emirates.
Experts recognise that genomic technology could be key in improving healthcare in the UAE. The Emirati Genome Program is also part of the country’s attempts to strengthen its position as a hub for innovation and research in the field of genomics.
Involved in the project is Abu Dhabi’s G42 Healthcare, which is using both its Biogenix Labs – the UAE’s first COVID-19 accredited large-scale detection laboratory – and its Omics Centre of Excellence – dubbed the region’s largest and most technologically advanced multi-omics facility – to analyse data anonymously.
0 Comments